Answers are grounded in this paper and cite their sources.
Demonstrates the therapeutic and diagnostic potential of nanomaterials for cardiovascular diseases, suggesting improved drug delivery to vascular lesions.
Cardiovascular diseases (CVDs) are a primary cause of death globally. A few classic and hybrid treatments exist to treat CVDs. However, they lack in both safety and effectiveness. Thus, innovative nanomaterials for disease diagnosis and treatment are urgently required. The tiny size of nanomaterials allows them to reach more areas of the heart and arteries, making them ideal for CVDs. Atherosclerosis causes arterial stenosis and reduced blood flow. The most common treatment is medication and surgery to stabilize the disease. Nanotechnologies are crucial in treating vascular disease. Nanomaterials may be able to deliver medications to lesion sites after being infused into the circulation. Newer point‐of‐care devices have also been considered together with nanomaterials. For example, this study will look at the use of nanomaterials in imaging, diagnosing, and treating CVDs.
No takes yet. Share an insight, caveat, or question.
Chopra et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: